English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA new center at the University of Chicago Medicine will provide strategic leadership to bring together researchers, healthcare providers and community members to eliminate Chicago’s chronic cancer disparities.
Tag: Kunle Odunsi
UChicago Medicine breaks ground on $815M project to build state’s first freestanding cancer care and research pavilion
The University of Chicago Medicine broke ground Tuesday on its $815 million project to build the state’s first and only standalone structure dedicated to cancer care and research. The 575,000-square-foot, seven-story pavilion builds off UChicago’s decades of work and leadership in cancer research and its prestigious National Center Institute designation as a Comprehensive Cancer Center.
NCCN names UChicago Medicine Comprehensive Cancer Center as 33rd member institution
The University of Chicago Medicine Comprehensive Cancer Center has been named as the newest member institution of the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of leading cancer centers. There are now 33 academic centers across the United States contributing multidisciplinary subject matter experts to 61 different panels determining the latest evidence-based expert consensus recommendations for risk assessment, prevention, evaluation and treatment, surveillance, supportive care, and survivorship throughout the cancer care continuum.
John Carpten named as the 2022 recipient of the Simon M. Shubitz Award and Lectureship
The 2022 Simon M. Shubitz Prize and Lecture was awarded to John Carpten, PhD, an internationally recognized expert in cancer genomics and precision oncology.
Roswell Park and University of Chicago Medicine Comprehensive Cancer Centers Awarded Nearly $9M for Ovarian Cancer Research
Researchers from Roswell Park Comprehensive Cancer Center and the University of Chicago Medicine Comprehensive Cancer Center are combining efforts after together securing a nearly $9 million grant from the National Cancer Institute (NCI) to develop new and better treatments for ovarian cancer.